Phase 3 Myeloma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are generally in good physical health and able to carry out daily activities, or your physical limitations are only due to pain or other local symptoms from your myeloma (confirm with trial site)
• You have been diagnosed with multiple myeloma according to recognised international guidelines
• You have already received between one and three rounds of treatment for your myeloma, which must have included at least two cycles of either a treatment targeting a protein called CD38, or a drug called lenalidomide
• Your myeloma must be detectable through specific tests at the time of screening

Who may not be able to join:

• You have a history of a condition called amyloidosis, which involves abnormal protein build-up in tissues (confirm with trial site)
• You have a form of myeloma where large numbers of abnormal plasma cells are found in the blood (known as plasma cell leukemia), or your blood contains too many of these cells
• You have a stomach or bowel condition that could affect how your body absorbs oral (swallowed) medicines
• You have an active condition affecting the brain or nervous system, or a type of myeloma that does not produce measurable proteins in the blood or urine (known as non-secretory myeloma)

Important: Always verify eligibility with the trial site directly before applying.